These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37969361)

  • 1. Risk factors and a prognostic model for patients with borderline resectable locally advanced T3-4N0-1 non-small cell lung cancer: a population-based study.
    Liu Y; Lai H; Zhang R; Xia L; Guo C; Liu L
    Transl Cancer Res; 2023 Oct; 12(10):2837-2851. PubMed ID: 37969361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a dynamic survival nomogram for metastatic non-small cell lung cancer based on the SEER database and an external validation cohort.
    Wang Q; Wang Y; Wang X; Nakamura Y; Hydbring P; Yamauchi Y; Zhao X; Cao M
    Transl Lung Cancer Res; 2022 Aug; 11(8):1678-1691. PubMed ID: 36090634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Resectable N2 in NSCLC: A Single Center Experience and Review of the SEER Database.
    Wang YQ; Liu XD; Bai WL; Li SQ
    Front Oncol; 2021; 11():647546. PubMed ID: 33981606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and prognostic factors of combined small cell lung cancer: development and validation of a nomogram based on the SEER database.
    Yang L; Zhou Y; Wang G; Liu D; Chen B; Pu D; Correale P; Rades D; Tomita Y; Inno A; Santarpia M; Li Y; Li W
    Transl Lung Cancer Res; 2021 Nov; 10(11):4250-4265. PubMed ID: 35004254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a nomogram for predicting overall survival of resected N2 non-small cell lung cancer patients undergoing neoadjuvant radiotherapy.
    Shi J; Peng B; Wang C; Zhou X; Lu T; Xu R; Chang X; Shen Z; Wang K; Xu C; Zhang L
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11779-11790. PubMed ID: 37407846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ipilimumab plus nivolumab and chemoradiotherapy followed by surgery in patients with resectable and borderline resectable T3-4N0-1 non-small cell lung cancer: the INCREASE trial.
    Dickhoff C; Senan S; Schneiders FL; Veltman J; Hashemi S; Daniels JMA; Fransen M; Heineman DJ; Radonic T; van de Ven PM; Bartelink IH; Meijboom LJ; Garcia-Vallejo JJ; Oprea-Lager DE; de Gruijl TD; Bahce I
    BMC Cancer; 2020 Aug; 20(1):764. PubMed ID: 32795284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nomogram for predicting overall survival in patients with resected non-small cell lung cancer treated with chemotherapy.
    Zeng Y; Mayne N; Yang CJ; Liu J; Cui F; Li J; Liang W; He J;
    Transl Lung Cancer Res; 2021 Apr; 10(4):1690-1699. PubMed ID: 34012785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pleural invasion on survival of patients with small cell lung cancer: Propensity score analysis and nomogram establishment based on the SEER database.
    Yang J; Yin H; Liu M; Zou G; Yu B
    Front Surg; 2023; 10():1108732. PubMed ID: 36911624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Positive Lymph Node Ratio Predicts Survival in T
    Liao Y; Yin G; Fan X
    Front Oncol; 2020; 10():1356. PubMed ID: 32903785
    [No Abstract]   [Full Text] [Related]  

  • 10. Construction and validation of prognostic nomograms for elderly patients with metastatic non-small cell lung cancer.
    Sun H; Liu M; Yang X; Ren Y; Dai H; Wang C
    Clin Respir J; 2022 May; 16(5):380-393. PubMed ID: 35514033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival Nomogram for Stage IB Non-Small-Cell Lung Cancer Patients, Based on the SEER Database and an External Validation Cohort.
    Zuo Z; Zhang G; Song P; Yang J; Li S; Zhong Z; Tan Q; Wang L; Xue Q; Gao S; Sun N; He J
    Ann Surg Oncol; 2021 Jul; 28(7):3941-3950. PubMed ID: 33249521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and validation of a nomogram model to predict the overall survival rate of esophageal cancer patients receiving neoadjuvant chemotherapy: A population-based study.
    Yang Y; He C
    Front Surg; 2022; 9():1066092. PubMed ID: 36743892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Nomogram including AJCC Stages Could Better Predict Survival for NSCLC Patients Who Underwent Surgery: A Large Population-Based Study.
    Shang X; Yu H; Lin J; Li Z; Zhao C; Sun J; Wang H
    J Oncol; 2020; 2020():7863984. PubMed ID: 32565807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a nomogram for predicting overall survival in patients with stage III-N2 lung adenocarcinoma based on the SEER database.
    Zhang S; Xiao X; Qin X; Xia H
    Transl Cancer Res; 2023 Oct; 12(10):2742-2753. PubMed ID: 37969392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nomogram for the prediction of overall survival in patients with stage II and III non-small cell lung cancer using a population-based study.
    Liao Y; Wang X; Zhong P; Yin G; Fan X; Huang C
    Oncol Lett; 2019 Dec; 18(6):5905-5916. PubMed ID: 31788064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Nomogram predicting the overall survival of patients with pancreatic cancer treated with radiotherapy: a study based on the SEER database and a Chinese cohort.
    Dong X; Wang K; Yang H; Cheng R; Li Y; Hou Y; Chang J; Yuan L
    Front Endocrinol (Lausanne); 2023; 14():1266318. PubMed ID: 37955009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival nomogram for high-grade bladder cancer patients after surgery based on the SEER database and external validation cohort.
    Li Y; Chen T; Fu B; Luo Y; Chen L
    Front Oncol; 2023; 13():1164401. PubMed ID: 37397381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a prognostic model of resectable small-cell lung cancer: a large population-based cohort study and external validation.
    Wang Y; Pang Z; Chen X; Yan T; Liu J; Du J
    J Transl Med; 2020 Jun; 18(1):237. PubMed ID: 32539859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and validation of prognostic nomogram and clinical characteristics for ovarian endometrioid carcinoma: an SEER-based cohort study.
    Ye W; Wang Q; Lu Y
    J Cancer Res Clin Oncol; 2023 Nov; 149(15):13607-13618. PubMed ID: 37515614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.